In the news

February 9, 2024

Cancer institute researchers edge closer to delivering personalized medicine to cancer patients

For the first time, Purdue researchers prove that measuring mechanical motions in living cancer tissues is a viable and promising approach for predicting chemoresistance.

January 13, 2024

Mesecar Purdue cancer institute directorship supported with $5 million Walther gift

Andrew Mesecar, recently ratified by the Purdue University Board of Trustees as the Robert Wallace Miller Director of the Purdue Institute for Cancer Research (PICR), will be supported in the role by the Walther Cancer Foundation Director’s Fund, a $5 million gift from the Walther Cancer Foundation.

January 3, 2024

Exposure to cigarette smoke increases cancer risk in dogs

A long-term study following Scottish terriers indicates cigarette smoke exposure leads to a sixfold increase in the risk of bladder cancer

December 4, 2023

Discovery points to new approach to treating liver cancer

Boosting levels of a naturally occurring enzyme could improve the effectiveness of the liver cancer drug sorafenib.

November 14, 2023

Purdue pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells

Zhong-Yin Zhang of Purdue University’s College of Pharmacy and the Purdue Institute for Drug Discovery leads a team that has created a novel cancer immunotherapy compound that degrades an enzyme found in cancer cells and T cells. The research was published in the Royal Society of Chemistry’s peer-reviewed journal Chemical Science.

November 14, 2023

Andrew D. Mesecar named Distinguished Professor of Biochemistry

Andrew D. Mesecar, Distinguished Professor of Biochemistry, Agriculture.

October 14, 2023

Purdue names new pediatric cancer research center for the late Tyler Trent

More than four years after Tyler Trent’s passing from the rare bone cancer osteosarcoma, Purdue University is ensuring that the memory of the former graduate and devoted Boilermaker football fan will live on through research to cure his disease and other pediatric cancers.

October 9, 2023

Boilermaker fans prepare to Hammer Down Cancer

WEST LAFAYETTE, Ind. – The Purdue football game Saturday (Oct. 14) against Ohio State University is a major event in the 2023-24 Hammer Down Cancer Game series in support of the Purdue Institute for Cancer Research.

October 4, 2023

Mesecar named director of the Purdue Institute for Cancer Research

WEST LAFAYETTE, Ind. – Andrew Mesecar, Distinguished Professor of Biochemistry and the Walther Professor in Cancer Structural Biology, has been named assistant vice president for research and director of the Purdue Institute for Cancer Research (PICR) after serving since August 2022 as interim director. Chosen for the position after a nationwide search, his new role was effective Sept. 1.

September 5, 2023

First-in-class targeted microRNA therapy slows cancer tumor growth

A new therapy for cancer uses microRNA to slow or stop division of cancer cells.